Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Shares Outstanding (Diluted Average) (2016 - 2022)

Phibro Animal Health has reported Shares Outstanding (Diluted Average) over the past 10 years, most recently at $40.5 million for Q1 2022.

  • For Q1 2022, Shares Outstanding (Diluted Average) changed 0.0% year-over-year to $40.5 million; the TTM value through Mar 2022 reached $40.5 million, changed 0.0%, while the annual FY2019 figure was $40523.0, 0.34% changed from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2022 was $40.5 million at Phibro Animal Health, roughly flat from $40.5 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $40.6 million in Q3 2018 and troughed at $40348.0 in Q1 2018.
  • A 5-year average of $32.4 million and a median of $40.5 million in 2019 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): soared 100562.65% in 2018 and later decreased 0.14% in 2019.
  • Year by year, Shares Outstanding (Diluted Average) stood at $40.5 million in 2018, then fell by 0.05% to $40.5 million in 2019, then changed by 0.0% to $40.5 million in 2020, then changed by 0.0% to $40.5 million in 2021, then changed by 0.0% to $40.5 million in 2022.
  • Business Quant data shows Shares Outstanding (Diluted Average) for PAHC at $40.5 million in Q1 2022, $40.5 million in Q4 2021, and $40.5 million in Q3 2021.